AbbVie ABBV-USDT perp on BloFin fails at 287.03 again and slips to 286.23: short bias, invalid above 287.13

BloFin added ABBV-USDT to its stock perps at 3:30 AM ET today. It is a linear USDT-margined contract on AbbVie (NYSE: ABBV), the pharma company behind Humira, Skyrizi and Rinvoq.

Contract

• Max 20x, contract value 0.01 ABBV, minimum order 1 contract.
• Funding every 8 hours, capped at +/-0.03%.
• Follows US market hours.

BloFin snapshot, 12:00 PM ET

• Last 286.23 against a 24h open of 286.56.
• 24h range 283.30 to 287.50. The 283.30 low was a single wick in the 9:30 candle.
• 24h volume about 25 ABBV, roughly 7K USDT, so books are very thin.
• Funding +0.0030%, slightly positive.

15m picture

Highs keep stalling at the same ceiling: 287.13, 287.01, 287.03, 287.03, then 286.90 in the latest candle. Lows had been holding near 286.30 to 286.45 and the 11:45 candle finally traded down to 286.23, the lowest low of the band.

Bias: SHORT

Four failures at 287.0 and a break of the band floor point lower. A 15m close under 286.23 targets 285.79 first, then 285.30.

Invalidation: a 15m close above 287.13.

Brand new contract with very thin volume, so a single order can move it. Size small.